Handelsblatt Morning Briefing: A bolt against Great Britain
Good morning dear readers, All of Europe is discussing Great Britain during these hours – not so much because of Brexit, but because of a … Read more
Dietmar Hopp
Curevac on Nasdaq: IPO with vaccine bonus
DThe Tübingen-based biotech company Curevac has already announced that it will go public, and the project is now gradually becoming concrete. With the IPO on … Read more
Tübingen-based biotech company Immatics makes its debut at Nasdaq
Frankfurt The German biotech company Immatics has now significantly strengthened its financial base with a listing on the US technology exchange Nasdaq. The Tübingen-based company … Read more
Tübingen-based biotech company Immatics makes its debut at Nasdaq
Frankfurt The German biotech company Immatics has now significantly strengthened its financial base with a listing on the US technology exchange Nasdaq. The Tübingen-based company … Read more
Tübingen-based biotech company Immatics makes its debut at Nasdaq
Frankfurt The German biotech company Immatics has now significantly strengthened its financial base with a listing on the US technology exchange Nasdaq. The Tübingen-based company … Read more
Tübingen-based biotech company Immatics makes its debut at Nasdaq
Frankfurt The German biotech company Immatics has now significantly strengthened its financial base with a listing on the US technology exchange Nasdaq. The Tübingen-based company … Read more